Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2007-04-25FDA Approved: FOCALIN XR — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN XR (dexmethylphenidate hydrochloride) from Sandoz Inc, resulting in an approved modi…
-
FDA approval · 2007-04-25FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
FDA approved a supplemental NDA for FOCALIN (dexmethylphenidate hydrochloride) from Sandoz Inc, indicating an approved change to the existin…
-
FDA approval · 2007-04-25FDA Approved: RITALIN — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for RITALIN (methylphenidate hydrochloride) submitted by Novartis Pharmaceuticals Corporation.
-
FDA approval · 2007-04-25FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) submitted by Eli Lilly and Company.
-
FDA approval · 2007-04-25FDA Approved: METHYLPHENIDATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for methylphenidate from Sandoz Inc, indicating an approved change to the product's labeling or …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-03-23FDA Approved: DEXTROAMPHETAMINE SULFATE EXTENDED-RELEASE — Supplemental Application (SpecGx LLC)
The FDA approved a supplemental application for Dextroamphetamine Sulfate Extended-Release submitted by SpecGx LLC. This action pertains to …
-
CLINICAL_TRIALS research · 2007-03-20Clinical Trial Update: Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning
A clinical trial update from UMC Utrecht examining how genetic risk for Attention Deficit Hyperactivity Disorder is expressed in brain funct…
-
CLINICAL_TRIALS research · 2007-03-20Clinical Trial Update: Magnetic Resonance Imaging of Brain Development in Attention Deficit Hyperactivity Disorder
The document provides an update on a clinical trial using magnetic resonance imaging to study brain development in individuals with Attentio…
-
CLINICAL_TRIALS trial_result · 2007-03-13Clinical Trial Update: Procedural Learning in Participants With ADHD [EARLY_Phase 1]
An early-phase 1 clinical trial update investigating procedural learning in individuals with ADHD; the current study status is unknown.
-
FDA approval · 2007-03-08FDA Approved: FOCALIN — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for FOCALIN (dexmethylphenidate hydrochloride) submitted by Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2007-03-02Clinical Trial Update: Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents [Phase 3]
This entry reports the completion of a Phase 3 trial evaluating the broader efficacy of atomoxetine for treating Attention Deficit Hyperacti…
-
CLINICAL_TRIALS research · 2007-02-28Clinical Trial Update: Study of Clonidine on Sleep Architecture in Children With Tourette's Syndrome (TS) and Comorbid ADHD [Phase 4]
A Phase 4 study evaluating the effects of clonidine on sleep architecture in children with Tourette syndrome and comorbid ADHD. The study st…
-
FDA approval · 2007-02-23FDA Approved: VYVANSE — Original Application (Takeda Pharmaceuticals America, Inc.)
FDA approved Vyvanse (lisdexamfetamine dimesylate) from Takeda as the original NDA (NDA021977) for the treatment of attention-deficit/hypera…
-
CLINICAL_TRIALS trial_result · 2007-02-14Clinical Trial Update: Dietary Intake and Nutrient Status of Children With ADHD
This update reports on a completed clinical trial investigating the dietary intake and nutrient status of children with ADHD.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Treatment With Atomoxetine Hydrochloride in Children and Adolescents With ADHD [Phase 4]
Phase 4 clinical trial update of atomoxetine hydrochloride for attention-deficit/hyperactivity disorder in children and adolescents has comp…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes [Phase 4]
Phase 4 trial evaluating symptomatic and functional outcomes of atomoxetine in children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Neuropsychological Functioning in Children With Attention-Deficit/Hyperactivity Disorder. [Phase 4]
Phase 4 trial update examining neuropsychological functioning in children with Attention Deficit Hyperactivity Disorder. The study sponsored…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: An Open-Label Study of Atomoxetine in Adolescents With Attention-Deficit/Hyperactivity Disorder [Phase 3]
An open-label Phase 3 study evaluating atomoxetine in adolescents with Attention Deficit Hyperactivity Disorder has been completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: An Open-Label Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder [Phase 3]
An open-label Phase 3 trial evaluating atomoxetine in children with Attention Deficit Hyperactivity Disorder has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-13Clinical Trial Update: Maintenance of Benefit With Atomoxetine Hydrochloride in Adolescents With ADHD [Phase 4]
This Phase 4 trial update reports sustained benefit of atomoxetine hydrochloride in adolescents with Attention-Deficit/Hyperactivity Disorde…
-
CLINICAL_TRIALS trial_result · 2006-11-07Clinical Trial Update: Supplementation of Phosphatidylserine (PS) and n-3 Long Chain Fatty Acids (EPA, DHA) in Children With ADHD [Phase 2]
Phase 2 trial evaluating supplementation with phosphatidylserine and omega-3 fatty acids in children with ADHD. The study status is complete…
-
CLINICAL_TRIALS research · 2006-10-26Clinical Trial Update: Sleep Disorders in Children With ADHD
The document provides an update on a clinical trial investigating sleep disorders in children with ADHD; the trial status is listed as UNKNO…
-
FDA approval · 2006-10-19FDA Approved: STRATTERA — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Strattera (atomoxetine hydrochloride) submitted by Eli Lilly and Company. The supplemental actio…
-
CLINICAL_TRIALS trial_result · 2006-10-11Clinical Trial Update: Atomoxetine vs Placebo in the Treatment of ADHD in Swedish Children and Adolescents [Phase 3]
A Phase 3 trial evaluating atomoxetine against placebo for ADHD in Swedish children and adolescents has completed.
-
FDA approval · 2006-09-07FDA Approved: CONCERTA — Supplemental Application (Janssen Pharmaceuticals, Inc.)
The FDA approved a supplemental application for CONCERTA (methylphenidate hydrochloride) from Janssen Pharmaceuticals, Inc.